PHAT insider trading

Open-market stock trades by Phathom Pharmaceuticals (PHAT) executives and directors: who bought or sold, how many shares, at what price and when.

PHAT insider trades

DateInsiderRoleTradeSharesPriceValue
Nov 3, 2025Breedlove Robert CharlesPrincipal Accounting OfficerSell524$13.51$7.08K
Sep 5, 2025Breedlove Robert CharlesPrincipal Accounting OfficerSell461$12.09$5.57K
Jul 16, 2025Breedlove Robert CharlesPrincipal Accounting OfficerSell1,692$8.36$14.15K
May 21, 2025Topper James NdirectorBuy3,780$3.86$14.61K
May 14, 2025Topper James NdirectorBuy6,300$3.32$20.92K
May 13, 2025Topper James NdirectorBuy1,120$3.16$3.54K
May 12, 2025Topper James NdirectorBuy12,601$3.04$38.30K
May 9, 2025Topper James NdirectorBuy2,226$3.62$8.05K
May 9, 2025Topper James NdirectorBuy33,376$3.19$106.56K
May 7, 2025Parikh AsitdirectorBuy5,000$2.40$11.98K
May 6, 2025Parikh AsitdirectorBuy5,000$2.60$13.00K
Apr 7, 2025Henderson MollyCFO and CBOSell3,678$4.55$16.74K
Mar 13, 2025Parikh AsitdirectorBuy10,000$4.42$44.20K
Jan 21, 2025Henderson MollyCFO and CBOSell6,583$6.59$43.37K
Jan 21, 2025Nabulsi AzmiChief Operating OfficerSell7,886$6.59$51.96K

Updated 2026-11-03 04:20 UTC